This page shows the latest medicines optimisation news and features for those working in and with pharma, biotech and healthcare.
The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of medicines and other 'biomedical innovations' ... These areas include economic growth, digital
Strong launches for new medicines Ocrevus, Tecentriq and Alecensa, especially in Germany, partially offset the loss in Europe. ... The FreeStyle Libre has not been formally reviewed by NICE, but by England’s new network of Regional Medicines
There has also been “a degree of convergence” among the people and bodies that work on assessing new medicines, he added, whether they be involved with NICE, the Cancer Drugs Fund ... However, a warning note about partnership working was sounded by
But pharmaceutical companies do – and they are perfectly placed to help the NHS improve medicines optimisation. ... In reality, many pharma companies have adapted their operations to develop processes and strategies to collect RWE for their medicines.
Industry agreed to the PPRS in order to improve the use of innovative medicines in the UK. ... We are working with the Department of Health, NHS England and government to ensure action in key areas such as changes to NICE's decision making framework and
Paul Chrisp, programme director for the medicines and prescribing centre at NICE, said: “The NICE guideline on medicines optimisation sets out what needs to be done by all health and social ... Medicines optimisation is not a new concept. “This
More from news
Approximately 10 fully matching, plus 16 partially matching documents found.
OptiMiSe is an innovative meetings based learning journey developed in line with the NICE Quality Standards for MS and the Royal Pharmaceutical Society’s (RPS) four principles of medicines optimisation: ... Furthermore, 100% of the MSSNs engaged in
In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... Considerable effort was directed towards medicines optimisation and building an evidence base for the wider use of NOACs in
Industry must assume a responsibility to move beyond just the manufacture of medicines. ... Create a reliable supply chain ensuring that patients get the right medicine at the right time, supporting medicines optimisation.
All with negative implications for patients - but to date focusing on specialist medicines. ... It is clear that the medicines optimisation agenda is of more importance now than ever.
The global recession has changed the way the industry needs to market its medicines. ... In England the NHS-driven Medicines Optimisation programme will this year engage local payers and providers on the ability of good medicines usage to improve patient
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation. ... ensure appropriate medicines and technologies are available to all eligible
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
The Government recently announced changes to the AAC to ensure that the most promising medicines, diagnostic tools and digital services get through the clinical development and regulatory approval process faster. ... and provide insights into how
Regional Medicines Optimisation Committees(RMOCs), which were launched last year, have been playing a pivotal role in working with NHS commissioners and providers on best value biologics and helping them to ... by 2020/21 if the NHS embraces the use of
The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.
The event aims to help industry develop stronger relationships with leaders from NHS England, Regional Medicines Optimisation Committees (RMOCs), Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs), and influence
The CCGs will be monitored by four Regional Medicines Optimisation Committees(RMOCs) which were launched recently to avoid duplication when evaluating medicines, particularly those which are not evaluated by NICE. . ... Thanks to powerful data analytics
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...